Fibrogenesis encompasses the deposition of matrix proteins, such as collagen I, by hepatic stellate cells (HSCs) that culminates in cirrhosis. Fibrogenic signals drive transcription of procollagen I, which enters the endoplasmic reticulum (ER), is trafficked through the secretory pathway, and released to generate extracellular matrix. Alternatively, disruption of procollagen I ER export could activate the unfolded protein response (UPR) and drive HSC apoptosis. Using a small interfering RNA screen, we identified Transport and Golgi organization 1 (TANGO1) as a potential participant in collagen I secretion. We investigated the role of TANGO1 in procollagen I secretion in HSCs and liver fibrogenesis. Depletion of TANGO1 in HSCs blocked collagen I secretion without affecting other matrix proteins. Disruption of secretion led to procollagen I retention within the ER, induction of the UPR, and HSC apoptosis. In wild-type (WT) HSCs, both TANGO1 and the UPR were induced by transforming growth factor b (TGFb). As the UPR up-regulates proteins involved in secretion, we studied whether TANGO1 was a target of the UPR. We found that UPR signaling is responsible for up-regulating TANGO1 in response to TGFb, and this mechanism is mediated by the transcription factor X-box binding protein 1 (XBP1). In vivo, murine and human cirrhotic tissue displayed increased TANGO1 messenger RNA levels. Finally, TANGO1
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L iver cirrhosis is the leading cause of end-stage liver disease and affects millions worldwide. (1, 2) Cirrhosis is characterized by fibrogenesis and secretion and deposition of extracellular matrix proteins, which is primarily mediated by activated hepatic stellate cells (HSCs). (1) (2) (3) (4) The dominant matrix protein produced and secreted by HSCs is collagen I. Collagen I consists of two procollagen isoforms, a 1 and a 2 (139 and 129 kD, respectively), which are cotranslationally translocated into the endoplasmic reticulum (ER).
Once in the ER, procollagen I is folded with the help of several chaperones, including heavy chain binding protein (BiP), protein disulfide isomerase (PDI), and the collagen-specific chaperone, heat shock protein 47. (5) (6) (7) Whereas the mechanisms of procollagen I folding are well established, procollagen I export from the ER is poorly understood. (8) Furthermore, given that procollagen I expression is increased in HSCs by fibrogenic signals, the proteins involved in ER export of procollagen I must be properly regulated to accommodate the increase in procollagen I trafficking and avoid disrupting cellular homeostasis.
An emerging protein that may regulate procollagen I export from the ER is TANGO1 (Transport and Golgi organization 1). (9) (10) (11) TANGO1 was originally identified in a screen for proteins involved in Golgi organization. (9) In vitro studies in chondrocytes found that TANGO1 specifically mediates procollagen VII export without affecting general protein secretion. (10) Additionally, in vivo studies in TANGO1 -/-mice found that global loss of TANGO1 is embryonic lethal attributable to skeletal abnormalities. (11) Whereas TANGO1 is clearly critical for early development, the importance of TANGO1 in collagen-mediated pathologies, such as hepatic fibrogenesis, remains unexplored.
Regulation of protein export from the ER is key to cellular homeostasis, given that disruption of this process can lead to ER stress and activation of the unfolded protein response (UPR). The UPR consists of three signaling pathways mediated by the ER membrane proteins inositol-requiring enzyme-1 alpha (IRE-1a), activating transcription factor 6 alpha (ATF6a), and protein kinase RNA-like ER kinase (PERK). UPR signaling aims to reduce the ER protein load by repressing global protein translation and promoting expression of selective genes involved in protein folding, secretion, and degradation. (12) (13) (14) Transcription factors such as X-box binding protein 1 (XBP1) and activating transcription factor 4 (ATF4) are critical for selective upregulation of UPR targets that facilitate resolution of ER stress. (15) If TANGO1 is involved in procollagen I secretion, it is reasonable to predict that the UPR may regulate TANGO1 in response to increased procollagen I production during HSC activation, similar to beta cells in response to increased insulin secretion. (16) (17) (18) If ER stress is unresolved, cells undergo apoptosis. Proapoptotic UPR signaling is mediated by the transcription factor, C/EBP homologous protein (CHOP), and its target, death receptor 5 (DR5; also known as tumor necrosis factor-related apoptosis-inducing ligand receptor 2). (19) Given that HSC apoptosis is favorable for fibrosis resolution, procollagen I retention in the ER and ensuing UPR signaling could have additional antifibrotic actions above and beyond reduced collagen I release. (20, 21) We hypothesize that TANGO1 is crucial for liver fibrogenesis through mediating secretion of procollagen I. Furthermore, we predict that, in the absence of TANGO1, procollagen I would be retained in the ER leading to ER stress, induction of the UPR, and HSC apoptosis. Here, we show that collagen I secretion from HSCs is dependent on TANGO1 expression, and loss of TANGO1 leads to procollagen I retention in the ER, which promotes UPR-mediated HSC apoptosis. Next, we uncovered a UPR signaling mechanism that up-regulates TANGO1 expression in response to profibrotic signals. Finally, we show that TANGO1 is critical for fibrogenesis in mice and is specifically up-regulated in HSCs in response to profibrotic stimuli. Together, our work reveals a unique role for TANGO1 and the UPR in facilitating collagen I secretion and fibrogenesis.
Materials and Methods

HSC TRANSFECTION AND TREATMENT
LX-2 cells or human HSCs (hHSCs, ScienCell, Carlsbad, CA) were transfected with a small interfering RNA (siRNA) against MIA3/TANGO1 (GE Dharmacon, LaFayette, CO) using Oligofectamine (Invitrogen, Waltham, MA). For rescue experiments, the plasmid pcDNA3-GFP-TANGO1-PE kindly provided by Dr. Vivek Malhotra (Centre for Genomic Regulation, Barcelona, Spain), or pcDNA-GFP-PE were transfected into LX-2 cells using Lipofectamine 3000 transfection reagent (Thermo Fisher, Waltham, MA). (10) Twenty-four hours posttransfection, cells were serum starved for 4 hours, followed by the indicated treatment. Transforming growth factor b (TGFb) was utilized at 10 ng/mL for all experiments. For experiments involving 4-phenylbuterate (4-PBA; Sigma: 1716-12-7, St. Louis, MO), serum starvation was performed in the presence of 10 lM of 4-PBA or vehicle.
IMMUNOBLOTTING
Cells were lysed in a modified RIPA buffer (20 mM of HEPES [pH 7.5], 0.5% deoxycholate [DOC], 0.2% sodium dodecyl sulfate [SDS] , 150 mM of NaCl, 2 mM of EDTA, and 1% Triton plus protease inhibitors) and centrifuged to remove cell debris. Lysates were denatured using 53 Lamelli buffer with dithiothreitol (conditioned media) or betamercaptoethanol (whole cell lysate), boiled, resolved using SDS/polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to nitrocellulose membrane. Membranes were blocked and incubated with primary antibodies overnight, followed by an appropriate secondary antibody, and developed. Purchased primary antibodies are listed in the Supporting Methods. The antibody against TANGO1 was generated by Pacific Immunology (Ramona, CA) as described. (10) All experiments are representative of a minimum of three independent experiments with quantification and statistics performed using ImageJ and Prism, respectively.
CONFOCAL MICROSCOPY
Cells were plated on fibronectin-coated wells, transfected, and treated with TGFb or vehicle. Following treatment, cells were fixed in 4% paraformaldehyde, permeabilized in 0.1% Triton X-100 in phosphatebuffered saline (PBS; except for Fig. 1C and Supporting Fig. S1B ), washed in PBS, and blocked in 5% bovine serum albumin (BSA) in PBS. Cells were incubated with primary antibodies overnight at 48C, followed by an appropriate fluorescently tagged secondary antibody. Antibodies were diluted in 5% BSA. DAPI was used to stain nuclei. All images were taken with a Zeiss LSM 5 Pascal (Germany) with the same laser intensity and power within each experiment. ImageJ was used to quantify the integrated density of each image, and the RG2B plugin was used to quantify colocalization. Primary antibodies are outlined in the Supporting Methods or described above.
QUANTITATIVE POLYMERASE CHAIN REACTION
After treatment, cells of liver tissue were harvested using Trizol and messenger RNA (mRNA) harvested using the Qiagen RNeasy kit (Qiagen, Germantown, MD). Equal amounts of mRNA were converted into complementary DNA (cDNA), and quantitative polymerase chain reaction (qPCR) was performed. (siTANGO1) or a scrambled control (siControl). Seventy-hours after transfection, TANGO1 expression was analyzed by immunoblotting with HSC70 serving as a loading control (quantification in the adjacent graph; *P < 0.05). (B) siControl or siTANGO1 LX-2 cells were treated with 10 ng/mL TGFb or a vehicle control for 24 hours. Conditioned media was harvested, separated by SDS-PAGE, and collagen I and fibronectin levels were analyzed using immunoblotting (upper panel; *P < 0.05). Coomassie stain was used to confirm equal loading between siControl and siTANGO1 pairs because conditioned media was harvested at different time points (lower panel). Quantification is displayed below the blots; n 5 4; *P < 0.05. (C) Confocal images were taken of extracellular collagen I deposition by siControl or siTANGO1 LX-2 cells treated with vehicle or TGFb. Cells were fixed, but not permeabilized, in order to eliminate staining for intracellular procollagen I. Both FITC and Differential interference Contrast (DIC) images are shown. Pixel intensity was determined using ImageJ, adjusted for cell number, and is displayed in the adjacent graph (scale bar 5 50 lm; n 5 4; *P < 0.001). (D) LX-2 cells were cotransfected with an siRNA against TANGO1 (or control siRNA) and a plasmid expressing exogenous TANGO1 (or a control plasmid) for 48 hours followed by TGFb treatment for 24 hours. Whole-cell lysate (left panel) was harvested and immunoblotted for TANGO1 and HSC70 (loading control). Conditioned media was also harvested, separated by SDS-PAGE, and collagen I secretion was examined by immunoblotting (right panel). Coomassie staining confirmed equal loading. N 5 5; *P < 0.05. and sex matched (n 5 5 for olive oil; n 5 6 for CCl 4 treatment). CCl 4 (0.5 lL/mg) was administered by intraperitoneal injection twice a week for 6 weeks. One day following the final injection, mice were sacrificed and livers harvested. Fibrosis was analyzed by Sirius Red staining (paraffin-embedded tissues; IHC Bioworld), hydroxyproline analysis, qPCR, immunoblotting, and immunofluorescence using protocols described. (24) Protein lysates were harvested by homogenizing liver tissue in a modified RIPA buffer (50 mM of Tris-HCl [pH 7.4], 1% Triton X-100, 0.2% sodium DOC, 0.2% SDS, and 1 mM of EDTA). All experiments and procedures were performed in accord with IACUC-approved protocols.
APOPTOSIS ANALYSIS
XBP1 CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS AND ANALYSIS
Lentiviral CRISPR plasmids against XBP1 were previously generated and packaged into HEK 293T cells. (25) LX-2 cells were infected with lentivirus and cells were selected with 2 ug/mL of blastocidin. XBP1 knockout was confirmed by qPCR. (25) To assess XBP1 splicing, mRNA was harvested from HSCs treated with TGFb or vehicle and underwent reversetranscriptase PCR. cDNA was purified, and PCR was performed using primers that span the spliced region of XBP1. The unspliced version of XBP1 contains a Providencia stuartli 164 (Pst1) restriction digest site, so the PCR product was digested with Pst1 (New England Biolabs, Ipswitch, MA) for 1 hour at 378C and resolved on a 1.7% Agarose gel. (25) 
SUPPORTING METHODS
Methods describing cell culture, qPCR primers, primary antibodies, viral packaging and infection, bile duct ligation (BDL), and the human biospecimens used are located in the Supporting Information.
Results
TANGO1 CONTRIBUTES TO COLLAGEN I SECRETION IN HSCs
To identify proteins involved in procollagen I trafficking through the secretory pathway, we performed a targeted siRNA screen purchased from GE Dharmacon. We focused on collagen I secretion because it is the most highly expressed collagen isoform in HSCs and commonly implicated in cirrhosis (Supporting Fig. S1A ).
(3) The screen consisted of siRNAs targeting 21 proteins involved in the secretory pathway. LX-2 cells were transfected with the siRNA and treated with TGFb or a vehicle control for 24 hours. Conditioned media was harvested and collagen I secretion was examined using immunoblotting (Supporting Table S1 ). Of the targets that were necessary for collagen I secretion (siRNA reduced collagen I secretion greater than 50% of control siRNA), the protein, TANGO1, was of interest because of its previously reported specificity for collagen VII secretion in osteoblasts.
(10) Thus, we chose to focus on the role of TANGO1 in collagen I secretion from HSCs.
TANGO1 MEDIATES COLLAGEN I SECRETION FROM HSCs
LX-2 cells were transfected with an siRNA targeting TANGO1 (siTANGO1), which reduced TAN-GO1 protein levels to 32 6 15% of cells transfected with a control siRNA (siControl; Fig. 1A ). Following transfection, cells were treated with TGFb, and collagen I secretion into the media was examined by immunoblotting. As anticipated, collagen I secretion increased after TGFb treatment in siControl cells, but both basal and TGFb-stimulated collagen I secretion were significantly reduced in siTANGO1 cells (Fig.  1B) . Interestingly, this effect was specific to collagen I, given that secretion of fibronectin, another matrix protein, was unaffected by loss of TANGO1. Collagen I secretion was also analyzed using confocal microscopy by staining nonpermeabilized cells for collagen I. Extracellular collagen I was significantly decreased in siTANGO1 cells compared to siControl cells (Fig.  1C) . Reduced collagen I deposition was also observed in primary hHSCs transfected with an siRNA against siTANGO1 (Supporting Fig. S1B ). To confirm the specificity of the siTANGO1 construct, we rescued TANGO1 expression using a pcDNA3-GFP-TANGO1-PE plasmid, kindly provided by Dr. Vivek Malhotra (Centre for Genomic Regulation, Barcelona, Spain). LX-2 cells were cotransfected with siTANGO1 and the TANGO1 plasmid or a control plasmid (Fig. 1D, left panel) . Cells were then treated with TGFb or vehicle for 24 hours, and collagen secretion into the conditioned media was analyzed by immunoblotting (Fig. 1D, right panel) . Exogenous TANGO1 expression rescued collagen I secretion in siTANGO1 cells. Thus, these complementary knockdown and rescue experiments confirm that TANGO1 mediates collagen I secretion in HSCs.
COLLAGEN I IS RETAINED IN THE ER UPON LOSS OF TANGO1
The impaired collagen I secretion led us to next examine whether procollagen I was retained intracellularly in siTANGO1 cells. siControl or siTANGO1 cells were treated with vehicle or TGFb, fixed, permeabilized, and costained for procollagen I and TANGO1. siTANGO1 cells displayed an increase in retained procollagen I in the presence of vehicle or TGFb treatment compared to siControl cells ( Fig. 2A) . To determine whether the retained procollagen I localized within the ER, LX-2 cells were costained for procollagen I and one of two ER markers: ER chaperone PDI or ERGIC53 (Fig. 2B) . The retained procollagen I colocalized with both PDI (top panel) and ERGIC53 (bottom panel), indicating that procollagen I is retained within the ER in the absence of TANGO1. Procollagen I retention within the ER was confirmed using Immunogold electron microscopy to visualize procollagen I (Supporting Fig. S1C ). In siControl cells treated with TGFb, procollagen I can be visualized in the cytosol, likely in transport to the plasma membrane for secretion (denoted by the asterisk), but in siTANGO1 cells, procollagen I remains at the ER (arrows). Given that increased protein retention in the ER can lead to ER stress and induction of the UPR, we next examined ER morphology using transmission electron microscopy to observe whether TANGO1 loss led to ER dilation or fragmentation, hallmarks of ER stress. Both ER dilation and fragmentation were evident upon TANGO1 knockdown (Fig. 2C) . Together, these data indicate that, upon loss of TANGO1 expression, procollagen I is retained within the ER and leads to ER stress.
KNOCKDOWN OF TANGO1 INDUCES THE UPR AND DRIVES HSC APOPTOSIS
Morphologic evidence of ER stress led us to next examine whether the UPR was activated in siTANGO1 cells by analyzing downstream targets of the three UPR signaling pathways. hHSCs were transfected with siControl or siTANGO1 and treated with vehicle, TGFb, or tunicamycin (Tuni; positive control) for matching time points. Immunoblotting revealed increased expression of the UPR marker, BiP, in siTANGO1 cells at basal conditions, and this expression was further up-regulated upon TGFb treatment (Fig. 3A) . qPCR analysis also revealed significant induction of several UPR markers upon TANGO1 loss either at basal conditions or upon TGFb treatment for 24 hours. These markers include ERdj4, ER degradation enhancer mannosidase alpha (EDEM), PDI, BiP, ERp57, Derlin-3, Wolfram syndrome 1 (WFS1), ERp72, and ATF4 (Fig. 3B) . (26) (27) (28) Growth arrest and DNA-damage-inducible 34 (Gadd34) was the only marker tested that did not show increased expression in response to TANGO1 knockdown. Interestingly, we also noted increased expression of UPR markers erdj4, EDEM, PDI, BiP, and ERp72 in TGFb-treated control cells, indicating that TGFb itself can drive some level of UPR signaling. Together, these data show that loss of TANGO1 leads to activation of the UPR, and that TANGO1 may prevent basal (or constitutive) ER stress.
Canonically, if ER stress is unresolved by the UPR, cells switch to a terminal phenotype and undergo UPR-mediated apoptosis. HSC apoptosis is critical to fibrosis resolution; thus, we were interested in whether loss of TANGO1 could promote apoptosis in hHSCs. We first analyzed expression of CHOP and DR5 and found that both were up-regulated in siTANGO1 cells, indicative of the UPR progressing to proapoptotic signaling (Fig. 4A) . We next studied the occurrence of hHSC apoptosis by examining caspase-3 cleavage. siTANGO1 cells exhibited increased caspase-3 cleavage at both basal conditions and in response to 24-hour TGFb treatment (Fig. 4B) . HSC death was confirmed using TUNEL staining, which revealed a higher percentage of TUNEL-positive cells in the absence of TANGO1 compared to control cells at 48 hours posttreatment (Fig. 4C) . To determine whether the observed apoptosis observed was a direct result of UPR signaling, we utilized two approaches. First, we pretreated siTANGO1 hHSCs with the chemical chaperone, 4-PBA, which ameliorates ER stress, and observed a reduction of apoptosis to control levels (Fig. 4C) . Second, we analyzed the role of CHOP in siTANGO1-induced cell death, given that CHOP is critical for induction of apoptosis during prolonged ER stress. Primary HSCs were isolated from WT or CHOP knockout mice, transfected with siRNA against TANGO1 or a scrambled control, and
FIG. 2.
Procollagen I is retained in the ER in the absence of TANGO1 expression. (A) siControl and siTANGO1 hHSCs were treated with TGFb or a vehicle control, fixed, permeabilized, and costained for procollagen I and TANGO1. Procollagen I retention was analyzed by ImageJ and densitometry is displayed in the adjacent graph (scale bar 5 10 um; n 5 4; *P < 0.05). (B) Confocal images of hHSCs transfected with siControl or siTANGO1 and treated with vehicle or TGFb. Cells were fixed, permeabilized, and costained for procollagen I and PDI (upper panel) or procollagen I and ERGIC53 (lower panel). Colocalization of procollagen I with either PDI or ERGIC53 were analyzed by ImageJ and displayed in the adjacent graphs (scale bar 5 10 lm; n 5 4; *P < 0.05). (C) Electron microscopy was performed on siControl and siTANGO1 hHSCs treated with TGFb or vehicle. siControl hHSCs displayed intact ER, whereas siTANGO1 hHSCs displayed distended and fragmented ER (for 10,0003 magnification, scale bar 5 2 lm; for 20,0003 magnification, scale bar 5 0.5 lm).
FIG. 3.
TANGO1 knockdown leads to UPR induction. Induction of the UPR was assessed using a combination of immunoblotting and qPCR to examine the expression of numerous downstream effectors. (A) siTANGO1 or siControl hHSCs were treated with TGFb for 0, 4, 8, or 24 hours. siControl cells were treated with Tuni for matching time points to serve as a positive control. Cells were lysed, separated by SDS-PAGE, and the UPR marker, BiP, was analyzed by immunoblotting. HSC70 served as a loading control. Blottings are representative of four separate experiments, and quantification is located in the adjacent panel (n 5 6; *P < 0.05). The red dashed line represents baseline expression (siControl, 0 hours). (B) Expression of UPR markers ERdj4, ERp57, Derlin-3, EDEM, BiP, WFS1, ERp72, Gadd34, PDI, and ATF4 in siControl or siTANGO1 hHSCs were analyzed by qPCR following 24-hour treatment with vehicle or TGFb. Tuni treatment served as a positive control. N 5 5; *P < 0.05. treated with TGFb or vehicle for 48 hours. Upon TUNEL analysis, we observed that WT mice displayed increased apoptosis when TANGO1 expression was reduced, whereas CHOP -/-cells transfected with siTANGO1 displayed no increase in cell death (Fig. 4D) . These data show that TANGO1 loss leads to UPR-mediated apoptosis.
The elevated apoptosis in siTANGO1 hHSCs led us to question whether the observed defect of collagen I secretion in Fig. 1 primarily occurred through a function of disrupted ER export or through HSC apoptosis. To address this issue, LX-2 cells were infected with a lentivirus encoding an shRNA against caspase-3, which ablates UPR-mediated apoptosis (Supporting Fig. S2A) . A scrambled shRNA served as a control. TANGO1 expression was subsequently reduced using an siRNA, and collagen I secretion into the conditioned media was analyzed. We found that reduced HSC apoptosis, through silencing caspase-3, did not rescue the collagen I secretion defect, indicating that apoptosis is an effect, rather than a cause, of impaired collagen I trafficking (Supporting Fig. S2B ).
To examine whether loss of TANGO1 led to apoptosis of other liver cell types, we transfected D,E) . Cells lacking XBP1 or control cells were treated with TGFb or vehicle, and cell lysate and conditioned media was harvested. TANGO1 expression (Lysate, D, n 5 3; *P < 0.01) and collagen I or fibronectin secretion (conditioned media, E, n 5 4; *P < 0.05) were measured using immunoblotting, following by ImageJ analysis displayed in the adjacent graphs. Abbreviation: Veh, vehicle.
immortalized hepatocytes (HepG2) with the siRNA against, TANGO1. These cells exhibited a much attenuated apoptotic response compared to control cells, indicative of a cell-type-specific response (Supporting Fig. S3A ). This may be attributed to less endogenous collagen I secretion by hepatocytes, given that we also observed attenuation of apoptosis in siTANGO1 cells when procollagen I expression is concomitantly decreased using a short hairpin RNA (shRNA) targeting collagen1a1 (Supporting Fig. S3B,C) .
TANGO1 IS A NOVEL ER STRESS-RESPONSIVE PROTEIN
Previous studies have indicated that the UPR is activated during, and critical for, HSC activation. (29, 30) We observed induction of the UPR in siControl HSCs after TGFb treatment, confirming that ER stress occurs during HSC activation (Fig. 3B) . A key aspect of UPR signaling involves up-regulation of proteins involved in ER export. The role of TANGO1 in procollagen I export, as well as the UPR activation upon TGFb treatment, led us to test whether the UPR up-regulated TANGO1 expression. LX-2s were treated with TGFb, Tuni, or a vehicle control, and TANGO1 expression was analyzed. TGFb treatment induced TANGO1 expression 2-fold, whereas Tuni treatment led to a larger 4-fold increase in TANGO1 expression (Fig. 5A) . Furthermore, pretreatment with 4-PBA blocked both the TGFb and Tuni induction of TANGO1, implicating that TANGO1 is upregulated downstream of the UPR. Given that we previously identified procollagen I retention as a key driver of UPR-mediated apoptosis when TANGO1 expression is reduced (Supporting Fig. S3C ), we next examined whether up-regulation of procollagen I expression was directly responsible for TGFb-induced TANGO1 expression. TANGO1 expression in response to TGFb was attenuated in cells where procollagen Ia1 expression was reduced, implicating a role for increased procollagen I expression in driving the UPR and TANGO1 expression (Supporting Fig. S3D ).
These data led us to examine how the UPR mediates TANGO1 expression. The UPR regulates several transcription factors, so we analyzed the genomic region upstream of the gene that encodes TANGO1 using the programs, TFBind and PROMO, to predict transcription factor binding sites. We identified potential binding sites for the UPR-activated transcription factor, XBP1. XBP1 is a transcription factor that is activated through splicing by phosphorylated IRE-1 and translocates to the nucleus, where it promotes gene expression. To examine whether XBP1 splicing occurs in response to TGFb treatment, we used PCR to amplify XBP1 from cDNA and digested the product with the restriction enzyme, Pst1, because spliced XBP1 no longer contains a Pst1 digestion site. (25) Indeed, we observed increased XBP1 splicing in TGFb-treated LX-2 cells (Fig. 5B) . We next utilized CRISPR-mediated knockout of XBP1 expression to generate two clonal LX-2 cell lines lacking XBP1 expression and a control cell line and analyzed whether XBP1 regulates TANGO1 expression (Fig. 5C ). (25) Basal TANGO1 expression was reduced in XBP1 knockout cells, and there was little-to-no increase in TANGO1 following TGFb treatment in either XBP-1 CRISPR cell line (Fig. 5D ). To confirm that TAN-GO1 function was similarly impaired, we analyzed collagen I secretion using immunoblotting. As expected, collagen I secretion, but not fibronectin secretion, was disrupted in the absence of XBP1 expression (Fig.  5E) . Together, these data show that XBP1 is critical for the UPR-mediated induction of TANGO1 and subsequent procollagen I export from the ER upon HSC activation.
TANGO1 EXPRESSION IS UP-REGULATED IN RESPONSE TO FIBROGENIC STIMULI
The in vitro up-regulation of TANGO1 in response to TGFb led us to examine whether TANGO1 expression is increased in cirrhosis. Analysis of human liver biopsies revealed a significant increase in TAN-GO1 expression in patients with cirrhosis compared to patients without cirrhosis (Fig. 6A) . Increased TAN-GO1 expression was also observed in two separate mouse models of fibrosis, CCl 4 and BDL, compared to their respective controls (Fig. 6B,C) . Next, we examined whether TANGO1 expression was increased specifically in HSCs. hHSCs, immortalized LX-2 cells, hepatocytes (HepG2), sinusoidal cells (transformed sinusoidal endothelial cells; TSECs), and cholangiocytes (NH2) were treated with TGFb for 24 hours and TANGO1 expression was analyzed using qPCR. LX-2 cells and hHSCs displayed a significant increase in TANGO1 (Fig. 6D) . HepG2 cells displayed a small, but statistically significant increase in TANGO1 expression, but this was dramatically lower than the changes observed in LX-2 or hHSCs (1.2-fold in HepG2 and 2.4-and 2.8-fold in LX-2 and hHSCs, respectively). TSEC and NHC2 cells displayed no increase in TANGO1 expression upon TGFb treatment. Increased TANGO1 expression in hHSCs following TGFb was further confirmed using immunoblotting (Fig. 6E) . These data highlight a celltype-specific increase in TANGO1 expression in response to TGFb.
TANGO1 IS CRITICAL FOR FIBROGENESIS
Finally, we sought to determine whether TANGO1 is involved in liver fibrogenesis. TANGO1-null mice are embryonic lethal attributable to altered bone development; thus, we utilized TANGO1 1/-mice to assess whether a reduction in TANGO1 expression impacts fibrogenesis.
(11) TANGO1 1/-mice displayed no obvious phenotypic differences before treatment or altered collagen deposition in liver, muscle, or skin (Fig. 7A [olive oil] and Supporting Fig. S4 ). However, a bone defect was observed in adult TANGO1
1/-mice, with decreased cortical thickness in the tibia compared to WT controls. Cirrhosis was induced in TANGO1 1/-or WT mice through intraperitoneal injections of 0.5 mg of CCl 4 /kg twice a week for 6 weeks, after which livers were harvested and fibrogenesis was analyzed. (24) .Olive oil injection served as a vehicle control. Both Sirius Red staining and hydroxyproline analysis showed less fibrogenesis following CCl 4 injection in TANGO1 1/-mice compared to WT littermates (Fig. 7A,B) . TANGO1
1/-mice also displayed no significant increase in profibrotic genes collagen type 1 alpha 1 (col1a1), alpha-smooth muscle actin (a-sma), tissue inhibitor of metalloproteinase 1 (timp1), or tgfb1 after CCl 4 treatment (Fig. 7C) , or protein expression of a-SMA or platelet-derived growth factor receptor beta (PDGFRb; Fig. 7D ). The reduced expression of procollagen I in TANGO1
1/-mice seemed counterintuitive at first glance given that TANGO1 regulates collagen secretion rather than transcription. These results suggest that increased retention of collagen I within the ER may drive HSC apoptosis or impaired HSC activation. To provide insight into this, we examined the number of HSCs within the liver using immunofluorescence to label HSCs through PDGFRb or Desmin staining. We found a reduction in the number of PDGFRb-or Desmin-positive cells in livers from CCl 4 -treated TANGO1
1/-mice compared to WT mice. This indicates that the observed reduction in fibrogenesis, at least in part, results from a reduced population of HSCs that may occur through HSC apoptosis (Supporting Fig. S5 ). Last, we confirmed the role of TANGO1 1/-in fibrogenesis using a second mouse model, where WT or TANGO1 mice were subjected to BDL to induce fibrogenesis, or a sham surgery. After 3 weeks, livers were harvested and analyzed for evidence of fibrosis. We found that
TANGO1
1/-mice that underwent BDL displayed less collagen deposition, as analyzed by Sirius Red staining or hydroxyproline assay compared to WT controls (Supporting Fig. S6A,B) , and lower expression of the fibrotic markers, col1a1, a-sma, timp1, and fibronectin (Supporting Fig. S6C ). In total, these studies highlights the importance of TANGO1 in mediating fibrogenesis both in vivo and in vitro.
Discussion
Previous studies on fibrosis often focused on mechanisms of procollagen I gene expression and matrix dynamics during fibrogenesis. (31) Conversely, details on the intracellular trafficking of procollagen I are lacking. This study identifies TANGO1 as a novel mediator of liver fibrosis by virtue of its ability to facilitate procollagen I processing and secretion in HSCs. We show for the first time that TANGO1 is critical for collagen I secretion in HSCs, and that loss of TANGO1 drives HSC apoptosis attributable to an inability of the cell to clear retained procollagen I from the ER. Furthermore, HSC activation induces TANGO1 expression, a mechanism that requires the UPR-regulated transcription factor XBP1. Thus, TANGO1 and the UPR are critical for collagen I secretion and HSC survival during HSC activation. Finally, we identify TANGO1 as a critical mediator of fibrogenesis in vivo (Fig. 8) .
ER stress is involved in numerous disease states, including liver diseases such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and alpha-1 antitrypsin deficiency. (14, 32) These diseases exhibit ER stress in hepatocytes, leading to parenchymal cell death and subsequent inflammation and fibrosis; however, the role of ER stress in HSCs during fibrogenesis is less understood. Only recently was the physiological importance of ER stress in HSCs identified, with UPR signaling as profibrogenic: critical for increased a-SMA expression and up-regulation of Smad-2. (29, 30, 33) ER stress is also implicated in idiopathic pulmonary fibrosis, where activation of lung fibroblasts by TGFb was dependent upon UPR activation. (34) Here, we identify UPR signaling to be critical for another key aspect of HSC activation: collagen I secretion. Thus, ER stress and induction of the UPR appear to be critical for the active secretory function of myofibroblasts. Our work highlights how up-regulation of TANGO1 by the UPR prevents constitutive ER stress in HSCs by meeting the secretory demands of increased procollagen I production.
A critical role of the UPR is up-regulation of proteins involved in the folding and trafficking of proteins through the secretory pathway. We initially observed UPR induction and HSC apoptosis in the absence of TANGO1, but also found that TANGO1 expression increased upon Tuni treatment. These data led us to hypothesize that TANGO1 expression is mediated by the UPR to facilitate clearance of procollagen I from the ER. Upon further investigation, we found that pretreatment of HSCs with the chemical chaperone, 4-PBA, ameliorated TGFb-or Tuni-induced TAN-GO1 expression, and similar results were observed when procollagen I expression was blocked using an shRNA. Finally, we uncovered that the mechanism of TANGO1 induction involved XBP1 as cells lacking XBP1 displayed no increase in TANGO1 expression following TGFb treatment. Together, these data outline a well-orchestrated mechanism by which HSCs are able to accommodate TGFb-mediated procollagen I folding and trafficking through UPR signaling and subsequent up-regulation of TANGO1, which, in turn, promotes collagen I exit from the ER.
The UPR may play an antifibrotic role in HSCs as well. Elimination of activated myofibroblasts is critical for fibrosis regression. (35) One mechanism by which this can occur is HSC apoptosis. (20, 21, 36) Induced nonphysiological ER stress in HSCs was shown to be antifibrotic, attributed to induction of cell death in cultured HSCs. (20, 37, 38) We observed increased UPR signaling in siTANGO1 cells, and increased expression of CHOP and DR5, genes involved in UPRmediated apoptosis. This prompted us to assess whether loss of TANGO1 in HSCs led to increased apoptosis. Both TUNEL staining and caspase-3 cleavage were increased in siTANGO1 cells, and these effects FIG. 8. TANGO1 is critical for collagen I secretion and fibrogenesis and is regulated by the UPR. Our data indicate a model wherein TANGO1 is critical for the ER export of procollagen I and its subsequent secretion [1] . Upon HSC activation, procollagen I transcription is increased, leading to ER stress and activation of the UPR [2] . If TANGO1 is lost, ER stress is unable to be resolved and HSC apoptosis occurs [3] . UPR signaling leads to phosphorylation of IRE-1a, which then facilitates splicing of the transcription factor XBP1 [4] . XBP1 then translocates to the nucleus and up-regulates expression of TANGO1. TANGO1 then facilitates ER export of procollagen I and fibrogenesis [5] .
were exacerbated by TGFb treatment. Furthermore, this apoptosis was a direct result of UPR signaling, given that both pretreatment with 4-PBA or loss of CHOP expression blocked HSC death in siTANGO1 cells. It is interesting to note the significant occurrence of apoptosis upon knockdown of TANGO1, even in the absence of TGFb treatment and HSC activation. We hypothesize that even quiescent HSCs require TANGO1 expression to mediate basal levels of collagen I secretion, and this is not restricted to cell lines, given that the primary mouse HSCs in Fig. 4D display the same phenotype. Furthermore, quiescent HSCs express significantly higher levels of collagen I than hepatocytes at basal conditions, potentially explaining why loss of TANGO1 drives apoptosis of quiescent HSCs, but not hepatocytes. (39) These findings indicate that while TANGO1 is crucial for accommodating increased procollagen I export from the ER, disruption of this process disrupts cellular homeostasis and drives apoptosis.
TANGO1 has previously been identified as an ERlocalized protein involved in procollagen VII export from the ER in chondrocytes. (10) TANGO1 is predicted to serve this role by recruiting procollagen VII, cytosolic proteins, and ER-Golgi intermediate compartment (ERGIC) vesicles to ER exit sites and facilitating the formation of large ER export vesicles that accommodate procollagen VII fibrils. (40, 41) We found a role for TANGO1 in selectively mediating collagen I secretion from HSCs, with loss of TANGO1 disrupting ER export of procollagen I, but not fibronectin. Interestingly, previous work in keratinocytes (that express procollagen VII) and fibroblasts (that primarily express procollagen I) found no alterations in collagen I secretion in vitro, whereas in vivo depletion of TAN-GO1 affected secretion of several collagen isoforms from chondrocytes and fibroblasts, including both collagen I and collagen VII. (10) This difference between HSCs and chondrocytes, as well as the differential effects of TANGO1 loss between HSCs and HepG2 cells observed in this study, may arise from the selective expression of TANGO1 isoforms. TANGO1 homologues, such as MIA1, MIA2, and OTOR, display restricted expression profiles, primarily expressed in chondrocytes, hepatocytes, and cochlea, respectively. (42) (43) (44) More research is needed to fully understand the specificity of TANGO isoforms in collagen secretion from different cell types.
Antifibrotic therapies that specifically target activated HSCs are critical to limit fibrogenesis and promote fibrosis regression. A goal for fibrosis treatment is to specifically drive apoptosis of HSCs to disrupt fibrogenesis while limiting damage to hepatocytes and other liver cells. Thus, we propose TANGO1 inhibition as an attractive target for antifibrotic therapies. In conclusion, these data provide novel insight into the mechanisms of procollagen I trafficking and fibrogenesis and lay the framework for future studies to identify targets for treating liver disease.
